Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

Some older adults may also choose to get the vaccine ... Hepatitis B can range from an acute, mild infection to a chronic ...

U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...

Researchers investigated characteristics of adolescent and young adult patients with HCC and risk factors that affect survival.

As the climate warms, the southwestern U.S. is increasingly experiencing weather whiplash as the region swings from drought ...

Nearly 40 million people could die worldwide by 2050 due to antimicrobially resistant infections, according to a new study ...

Illuminating the experience of people living with sickle cell could improve patients’ lives and enhance all of medicine ...

Scientists warn of a silent pandemic as deadly fungal infections evolve demanding urgent global action to combat antifungal resistance ...

DFI therapy cost the UK’s NHS up to £962 million ($1.27 billion) each year. In the U.S., amputation cost alone is $1.38 ...

The incidence of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis increases with age.1 Despite this trend, ...

Ascension Riverside, ArchWell, Wolfson Children's Hospital, UF Health and even Trevor Lawrence and Mayor Donna Deegan are ...

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.